Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 3/20 | 0.33 |
| ▸ | NOS1 | P29475 | 3/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368694 | 0.76 | EPHX1 (0.47) | ALDH1A1MEN1KMT2AMAPTPKM | |
| SCHEMBL10613600 | 0.72 | ALDH1A1 (0.48) | ALDH1A1MEN1KMT2AMAPTPKM | |
| SCHEMBL10613589 | 0.72 | ALDH1A1 (0.48) | ALDH1A1MEN1KMT2AMAPTPKM | |
| SCHEMBL368693 | 0.72 | NOS3 (0.38) | ALDH1A1MEN1KMT2AMAPTPKM | |
| SCHEMBL28528303 | 0.70 | CSNK1E (0.43) | ALDH1A1MEN1KMT2ACSNK1E | |
| SCHEMBL27977724 | 0.70 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2AMAPTPKM | |
| SCHEMBL12198798 | 0.70 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2AMAPTPKM | |
| SCHEMBL13715786 | 0.69 | ALDH1A1 (0.55) | ALDH1A1MEN1KMT2AMAPTPKM | |
| Azobenzene SCHEMBL15261802 | 0.69 | ALDH1A1 (0.71) | ALDH1A1MEN1KMT2AMAPTPKM | |
| SCHEMBL14471186 | 0.67 | EPHX1 (0.67) | SIGMAR1EPHX1MAOACSNK1E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107573326-B | Novel benzotriazole derivative and organic electroluminescent device using the same | 保土谷化学工业株式会社 | 2024-03-15 | — | — | CN | disclosed |
| EP-3432688-B1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2023-12-20 | — | — | EP | disclosed |
| CN-112079814-B | Benzotriazole derivative and organic electroluminescent device | 保土谷化学工业株式会社 | 2023-11-07 | — | — | CN | disclosed |
| US-11056653-B2 | Organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2021-07-06 | — | — | US | disclosed |
| CN-112079814-A | Benzotriazole derivative and organic electroluminescent device | 保土谷化学工业株式会社 | 2020-12-15 | — | — | CN | disclosed |
| US-20200328353-A1 | Organic Electroluminescence Device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-10-15 | — | — | US | disclosed |
| EP-2767534-B1 | NEW BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IN WHICH SAID DERIVATIVE IS USED | HODOGAYA CHEMICAL CO LTD (JP) | 2020-06-03 | — | — | EP | disclosed |
| EP-3432688-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2019-01-23 | — | — | EP | disclosed |
| EP-2409974-B1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-9842999-B2 | Benzotriazole derivative and an organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-12-12 | — | — | US | disclosed |
| US-20160164001-A1 | A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2016-06-09 | — | — | US | disclosed |
| EP-3029034-A1 | BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2016-06-08 | — | — | EP | disclosed |
| US-9123897-B2 | Benzotriazole derivatives and organic electroluminescent devices using the derivatives | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| US-9005776-B2 | Compound having benzotriazole ring structure and organic electroluminescent element | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-04-14 | — | — | US | disclosed |
| US-20140374721-A1 | NOVEL BENZOTRIAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE DERIVATIVES | HODOGAYA CHEMICAL CO., LTD (JP) | 2014-12-25 | — | — | US | disclosed |
| EP-2767534-A1 | NEW BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IN WHICH SAID DERIVATIVE IS USED | Hodogaya Chemical Co., Ltd. (JP) | 2014-08-20 | — | — | EP | disclosed |
| EP-2409974-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20120012831-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | SHINSHU UNIVERSITY (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160164001-A1 | A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | AHR, ARNT, NAT1 | ALDH1A1 215/4885MEN1 2403/4885KMT2A 142/4885 |
| US-20120012831-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | BRD4, ARNT, MLLT1 | ALDH1A1 1915/4885MEN1 2217/4885KMT2A 154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.